Over the next five years, medtech companies will face major disruption driven by structural and economic shifts in healthcare. Procedures are increasingly moving to lower-cost settings, reallocating volume from hospitals to ambulatory surgery centers. Provider consolidation, both horizontal and vertical, is changing how suppliers engage with larger and more integrated health systems. Providers are placing greater emphasis on case volume and site-of-care productivity to improve profitability, while purchasing decisions increasingly depend on clear economic and clinical value, including bundled payment models such as hip-and-knee programs. At the same time, persistent supply chain shocks and rising cost pressures are further challenging margins. To succeed, medtech leaders will need to adapt

Join for free to read